SEC 13F Intelligence

Boxer Capital, LLC / SRPT

Boxer Capital, LLC’s Sarepta Therapeutics Inc Position

Does Boxer Capital, LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 650.0K shares worth $81M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$81M
Q3 2024
Shares
650.0K
% of Portfolio
+3.98%
Quarters Held
11
position exited

Position History SRPT

Reported value by quarter
Q3 ’19: $41MQ3 ’19Q4 ’19: $29MQ2 ’22: $15MQ2 ’22Q3 ’22: $22MQ1 ’23: $106,818Q1 ’23Q2 ’23: $68,712Q3 ’23: $73MQ3 ’23Q4 ’23: $63MQ1 ’24: $84MQ1 ’24Q2 ’24: $103MQ3 ’24: $81MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024650.0K$81M+3.98%
Q2 2024650.0K$103M+5.41%
Q1 2024650.0K$84M+4.16%
Q4 2023650.0K$63M+3.12%
Q3 2023600.0K$73M+3.87%
Q2 2023600.0K$68,712+3.19%
Q1 2023775.0K$106,818+5.25%
Q3 2022200.0K$22M+1.24%
Q2 2022200.0K$15M+0.95%
Q4 2019225.0K$29M+1.64%
Q3 2019550.0K$41M+3.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of SRPT.